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1 Introduction
In Brazil as elsewhere, most children who live with
HIV are infected by mother-to-child (hereafter vertical)
transmission. Although vertical transmission of HIV is
preventable with existing testing and treatment
technologies, and transmission in this way has dropped
to less than 2 per cent in most developed countries,
only approximately 5–10 per cent of all women in
developing countries have access to preventing
mother-to-child transmission (PMTCT) (Prendergast et
al. 2007; UNAIDS 2006a). In the absence of any
intervention, the probability that women pass HIV to
their infants is approximately 15–30 per cent in
developed countries but 25–40 per cent in sub-
Saharan Africa (Prendergast et al. 2007; Connor et al.
1994; Italian Multicentre Study 1988). Without
interventions, approximately 66 per cent of vertical
transmission takes place in the peripartum1 period.
Most peripartum transmission (66 per cent) takes place
during childbirth and a third of cases take place in
utero, usually during the last trimester of pregnancy
(Prendergast et al. 2007). Much of the remainder is
attributable to postpartum and longer-term breast-
feeding. However, the risk of vertical transmission of
HIV can be radically reduced by providing highly active
antiretroviral therapy (HAART) to HIV-positive
pregnant women before childbirth and to their infants
for several weeks after birth (Prendergast et al. 2007;
Tonwe-Gold et al. 2007). Since most children who are
infected with HIV are infected by their mothers, the
single most effective way to address the paediatric
HIV/AIDS epidemic is to prevent vertical transmission
of HIV (Prendergast et al. 2007).
Preventing vertical transmission of HIV and
responding to the health and welfare needs of
children living with and affected by HIV/AIDS
requires significant resources as well as a robust
political commitment. As a result of its policies to
provide pregnant women and their newborns with
prophylactic HAART, Brazil has successfully reduced
vertical transmission of HIV/AIDS in recent years
(Figure 1). However, much less is known about the
welfare of children orphaned by AIDS in Brazil and
Latin America more broadly. Although a 2000 study
estimates that 32,000 children have been orphaned
as a result of the AIDS epidemic in Brazil
(Szwarcwald et al. 2000), few studies since have
examined either the social or medical needs of
children infected and affected by HIV/AIDS. Other
research has attempted to update the estimates on
AIDS orphans (França Junior et al. 2006), but the
conclusions of recent studies have been somewhat
limited by the paucity of information on paediatric
HIV/AIDS and AIDS orphans in Brazil.
This article appraises the available evidence to answer
the question: ‘Can a developing country support the
welfare needs of children affected by AIDS?’, for the
case of Brazil. Based on the Brazilian experience, we
argue that a developing country can indeed take
proactive steps to support the welfare needs of
children affected by HIV/AIDS. We hold that
irrespective of some uncertainties about the welfare
of children living with HIV/AIDS, Brazil’s
commitments to policies supporting these children
are best demonstrated by the country’s success in
dramatically reducing vertical transmission of HIV. In
turn, we attribute Brazil’s success in reducing vertical
transmission of HIV to its long-standing political
commitments to AIDS treatment, including
prophylactic antiretroviral therapy, which the country
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adopted over the objections of international donors
in the 1990s. Although Brazil supplemented
development of its HIV/AIDS programmes with
World Bank loans, the interventions which have had
the most demonstrable impact on child welfare,
including providing widespread access to HAART for
pregnant women and their infants, have been wholly
financed with local resources. This demonstrates
Brazil’s commitment and proactive, effective
response to addressing the welfare needs of children
affected and infected by HIV/AIDS.
2 The HIV/AIDS epidemic in Brazil
Brazil has a concentrated AIDS epidemic. HIV
prevalence in Brazil among the general population is
approximately five per 1,000 inhabitants (or 0.5 per
cent), which amounts to approximately 660,000
individuals. HIV prevalence is often higher than 5 per
cent in vulnerable subpopulations, such as injecting
drug users (IDUs), commercial sex workers and the
urban poor (Fonseca and Bastos 2007; Dourado et al.
2006). In spite of the increasing feminisation of the
AIDS epidemic in Brazil, during the last decade the
epidemic there has generally stabilised as incidence
rates levelled off in the industrialised, urban south-
east, where the epidemic has historically been
concentrated. In contrast with sub-Saharan Africa,
Brazil’s AIDS epidemic remains a largely urban
phenomenon; HIV prevalence in rural areas
throughout Brazil remains very low (Petersen et al.
2006). AIDS prevalence and incidence continues to
rise in the North-east region of Brazil as well as
among other vulnerable populations, such as in
homosexual men, the urban poor and IDUs (Dourado
et al. 2006; Hacker et al. 2006).
Recent estimates, based on the regular surveillance
of women attending prenatal clinics and maternities,
document HIV prevalence in Brazil as less than 0.5
per 1,000 (Szwarcwald et al. 2006), with slight
regional variation (Szwarcwald et al. 2000). This
overall low prevalence, coupled with the fact that
the epidemic has been concentrated among
vulnerable populations, such as IDUs (most of whom
are male in Brazil), homosexual men, and
hemophiliacs, has resulted in relatively low HIV
prevalence among women of reproductive health
age (Fonseca and Bastos 2007; Bastos et al. 2008).
Despite the progressive increase in the number of
women affected by the AIDS epidemic, relatively
low prevalence of HIV among women of
reproductive health age is an important factor
influencing Brazil’s relatively low rates of vertical
transmission of HIV, and in turn, Brazil’s relatively low
prevalence of paediatric AIDS.
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Figure 1 New AIDS cases for children under 13 in Brazil by type of HIV transmission (1983–2005)
Source National STD and AIDS Program of Brazil (2007).
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3 AIDS policy in Brazil
Brazil, a middle-income country with relatively well-
developed health infrastructure, is known for its
effective response to the AIDS epidemic. A social
movement for HIV/AIDS prompted early progressive
public responses to the HIV/AIDS epidemic, and Brazil
was the first developing country to begin treating AIDS
patients in its public health system in 1991 (Nunn 2009,
in press). Since 1996, over the objections of the World
Bank and other major donors, Brazil has provided free
and universal access to antiretroviral drugs for treating
People Living with HIV/AIDS (PLWHA). Although
Brazil has accepted US$425 million in World Bank
loans for developing AIDS programmes since 1994, the
terms of these loans have explicitly forbidden Brazil to
use the funds to finance drugs for AIDS treatment,
including drugs to prevent vertical transmission of HIV
(World Bank 1993, 1998, 2003).
Since the early 1990s, Brazil has prioritised both
treatment and prevention of HIV/AIDS. Working
around World Bank loan restrictions, Brazil used
World Bank funds to subsidise health infrastructure
development, capacity building for medical
professionals, epidemiological surveillance, and
partnerships with civil society organisations (Nunn
2009, in press). However, Brazil has always locally
financed drugs for treatment, including drugs to
prevent vertical transmission of HIV, out of the
federal local health ministry budget. HAART is now
offered in hundreds of clinics throughout the
country; Brazil scaled-up HAART from approximately
35,000 to 180,000 PLWHA during 1997–2007. In
2007, approximately 7,150 children received HAART.
Brazil’s treatment guidelines are based on the most
current clinical evidence available and include
comprehensive policies to treat all people living with
HIV/AIDS, including special populations such as
children and adolescents, pregnant women, IDUs,
and individuals co-infected with tuberculosis and
hepatitis. Critical components of Brazil’s treatment
guidelines include voluntary counselling and HIV
testing for all pregnant women receiving antenatal
care in public sector health clinics, policies to treat
HIV-infected women with HAART, and policies to
reduce the likelihood of vertical transmission of
HIV/AIDS during and after childbirth with
prophylactic administration of select antiretroviral
drugs to both mother and infant (Ministério de Saúde
2006; Programa Nacional de DST e Aids 2007).2
As a result of these policies, AIDS-related morbidity
and mortality have declined dramatically (Guimarães
2000, Teixeira et al. 2004; Marins et al. 2003), and
vertical transmission of HIV/AIDS has become rare in
Brazil (Ministério de Saúde 2006; Guimarães 2000).
These policies have won international acclaim from a
variety of different global health institutions, and
Brazil now offers important lessons for other
countries scaling-up AIDS treatment, particularly
middle-income countries with health infrastructure
and concentrated AIDS epidemics (Aceijas et al.
2007; Wools-Kaloustian and Kimaiyo 2006).
Other than a study that documents the cost of the
antiretroviral drugs for Brazil’s AIDS treatment
programmes (Nunn et al. 2007), little has been
written about the aggregate costs of Brazil’s
HIV/AIDS programmes and interventions. We note,
however, that during the last five years, local
spending on HIV/AIDS, and particularly AIDS
treatment, has far surpassed donor aid for HIV/AIDS
in Brazil. Although aggregate AIDS programme
expenditures were not available, Figure 2 highlights
Brazil’s local expenditures on antiretroviral drugs in
the years 2001–5, which totalled over US$1.1 billion.
In 2005, the last year for which data were available,
the Brazilian Ministry of Health (BMoH) spent
approximately US$414 million of its budget on
antiretroviral drugs; this sum alone approaches the
US$450 million in World Bank loan support over
more than a decade in Brazil. Though these might be
considered relatively large sums for drug expenditures
for one disease in a developing country, Brazil’s total
spending on drugs for HAART has never amounted to
more than 2 per cent of its now nearly US$20 billion
federal public health budget (Nunn et al. 2007). From
available data, it is unclear precisely how much Brazil
has spent on reducing vertical transmission of AIDS,
paediatric AIDS treatment, and welfare programmes
for children affected by HIV/AIDS; however, it is clear
that these types of programmes were generally
beyond the scope of programmes funded by World
Bank loans and have been financed domestically
rather than by international donors. Although costs of
Brazil’s programmes have risen in recent years, Brazil’s
political commitments to addressing the HIV/AIDS
epidemic are robust and unwavering; rising costs are
unlikely to threaten the sustainability of its
programmes.
One of the remarkable impacts of Brazil’s treatment
policies is the relatively low prevalence of paediatric
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HIV/AIDS which, in turn, has reduced the health and
economic challenges associated with meeting the
welfare needs of children affected and infected by
HIV/AIDS. Drugs costs for HAART alone average
US$2,500 per person per year in Brazil (Nunn et al.
2007), and aggregate health costs associated with
the treatment and care of PLWHA probably far
surpass this sum. Preventing vertical transmission of
HIV has been far less expensive than the treatment,
hospitalisation and social programme costs Brazil
would have faced in the absence of interventions to
prevent vertical transmission of HIV/AIDS.
We acknowledge that challenges in addressing the
welfare needs of children in other low- and middle-
income countries are compounded by higher HIV
prevalence, more fragmentary health infrastructure,
and insufficient health budgets. However, we posit
that the key reason Brazil faces relatively few
challenges associated with meeting the welfare
needs of children affected by AIDS is the fact that
the country developed an early, home-grown and
effective response to the HIV/AIDS epidemic.
We now turn to the health evidence that supports
these claims.
4 Vertical transmission of HIV and prevalence of
paediatric and adolescent HIV/AIDS in Brazil
Vertical transmission of HIV has declined in many
Latin American and Caribbean countries in recent
years. A recent study attributed the less than 1 per
cent rate of vertical transmission in four countries
from Latin America and the Caribbean (including
Brazil, Argentina, Mexico and the Bahamas) to the
successful implementation of antiretroviral treatment
and timely antiretroviral prophylaxis for HIV-positive
pregnant women (Read et al. 2007). Recent research
in Brazil also addresses the major achievements with
providing prophylactic antiretroviral therapy to
prevent vertical transmission of HIV as well as
challenges with scaling-up voluntary HIV testing and
HIV prophylaxis in Brazil’s more remote regions
(Matida et al. 2005; Souza-Junior et al. 2002; de
Brito et al. 2006).
From 1980 to 2005, approximately 10,400 Brazilian
AIDS cases were registered among children under
five; 3,905 cases were registered among those aged
5–12; and 8,075 were registered among those aged
13–193 (França Junior et al. 2006). The most recent
data from Brazil’s Sentinel Surveillance Program
estimates that HIV prevalence among all women
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Figure 2 Total cost of antiretroviral drugs in Brazil (2001–5)
Source Nunn et al. (2009, in press).
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delivering in public hospitals in Brazil is less than 1 per
cent, with relatively modest variation by geographic
region in Brazil (Programa Nacional de DST e Aids
2007).
Most AIDS cases among children under 13 years in
Brazil are attributable to vertical transmission of HIV
(Figure 1). The stabilisation of the AIDS epidemic
since the late 1990s and Brazil’s policies of providing
prophylactic antiretroviral therapy to HIV-positive
mothers just before childbirth have resulted in a
precipitous decline in the number of children aged
five years old or younger diagnosed with HIV.
According to data from Brazil’s sentinel surveillance
system, the number of new AIDS cases for children
under five peaked in 1997 (Figure 3).4 Vertical
transmission of HIV decreased from 16 per cent to
7 per cent for HIV-positive women receiving prenatal
care in Brazil’s public health system between 1997
and 2002 (de Brito et al. 2006). The number of AIDS
cases among adolescents aged 13–19 has remained
relatively stable since the mid-1990s (Figure 3).
In spite of Brazil’s relatively low rates of HIV
transmission, the National Sexually Transmitted
Disease (STD) and AIDS Program of Brazil estimates
that only 63 per cent of women who delivered in
public clinics had access to voluntary testing and HIV
prophylaxis prior to childbirth (Ministério de Saúde
2006; Programa Nacional de DST e Aids 2007).
Other related studies found that women who lived in
urban areas and women of higher educational strata
reported dramatically higher rates of than their
counterparts in rural areas and of lower
socioeconomic status. For example, only 19 per cent
of illiterate women had access to counselling, testing
and the appropriate prophylactic antiretroviral
regimens to prevent HIV, versus 64 per cent of
women who had completed eighth grade (Marins et
al. 2003).
In response to these challenges, BMoH recently
implemented a programme that requires compulsory
reporting for all pregnant women who test HIV
positive; implemented policies to reduce congenital
syphilis (which affects approximately 2 per cent of
women giving birth in public hospitals in Brazil)
(Ramos et al. 2007; Rodrigues 2004); and instituted
programmes to prevent vertical transmission of HIV in
all public health clinics in Brazil’s national health
system, the Sistema Único de Saúde (SUS).
Compulsory reporting of HIV for pregnant women
replaced the previous surveillance strategy, which only
required reporting of AIDS cases (Ministério de Saúde
2006; Programa Nacional de DST e Aids 2007).
Nunn and Bastos Financing the Welfare Needs of Children Affected by HIV/AIDS: The Case of Brazil112
Figure 3 AIDS cases among children and adolescents in Brazil (1983–2005)
Source National STD and AIDS Program of Brazil (2007).
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In spite of the aforementioned challenges associated
with access to HIV testing and prophylaxis for
pregnant women, vertical transmission of HIV
remains relatively low in Brazil, most likely because
access to essential testing and treatment
technologies is relatively stable in the south and
south-east regions, which have the highest HIV
prevalence. São Paulo, for example, constitutes
25 per cent of the Brazilian population and
represents 50 per cent of all AIDS cases in Brazil. In
São Paulo, an estimated 85 per cent of women
receive comprehensive prenatal care, including HIV
testing, counselling and requisite prophylaxis to
prevent vertical transmission of HIV. For women
who have not received antenatal care (an estimated
12 per cent of all women delivering in São Paulo),
the São Paulo state health ministry administers rapid
HIV tests just prior to childbirth in order to
determine whether to administer HAART
prophylactically (Matida et al. 2005). This suggests
that the unmet need for HIV testing necessary to
prevent vertical transmission of HIV is quite low in
São Paulo, the Brazilian state with the highest
prevalence of HIV. However, the decline in rates of
vertical HIV transmission has been less pronounced in
the less-developed regions of the country, with
more fragmentary health infrastructure, including the
north and north-eastern regions (Aceijas et al. 2007).
In addition to its policies of preventing vertical
transmission of HIV, Brazil offers HAART to all
children and adolescents living with HIV/AIDS. In
2007, approximately 7,150 children and adolescents
were receiving HAART in Brazil’s public health
system. Although life expectancy for adults living
with HIV/AIDS has improved dramatically as a result
of free and universal access to HAART (Bastos et al.
2008; Marins et al. 2003), less is known about the
survival impacts of providing HAART to children in
Brazil. To date, only one small study of less than 400
patients has examined AIDS-related morbidity and
mortality trends among children in Brazil. The study
finds that the risk of morbidity and mortality
overwhelmingly declined for HIV-positive children
taking HAART (Candiani et al. 2007). To date, no
study has systematically examined the population
impacts of providing free and universal access to
treatment on the survival of children and adolescents
living with HIV/AIDS in Brazil. Nevertheless, HAART
generally is associated with delayed onset of AIDS
and improved life expectancy, and has likely reduced
AIDS-related morbidity and mortality among the
population of children and adolescents living with
HIV/AIDS in Brazil (Souza-Junior et al. 2002).
Only one study has examined the costs of paediatric
AIDS treatment in Brazil. The small study of
approximately 300 children, conducted in one of
Brazil’s best specialty hospitals, finds that the average
cost of drugs for HIV prophylaxis to prevent vertical
transmission of HIV averaged approximately US$500
per child, while the cost of drugs for treating a child
living with HIV/AIDS averaged approximately
US$4,000. Average costs of hospitalisation for HIV-
positive children were in the range of
US$450–10,000 per child, depending on the child’s
health state at the time of admission (Marques et al.
2007). These costs may not be representative of
broader trends or standards of clinical care in greater
Brazil, but do provide some preliminary insight into
the costs associated with treating children living with
HIV/AIDS. These costs are not excessive for Brazil,
which spends nearly US$20 billion annually on health
programmes and approximately US$600 per capita on
health expenditures, but might be out of the realm of
possibility for other developing countries with higher
HIV prevalence and greater budget constraints.
5 Prevalence of orphans due to AIDS in Brazil
and the policy response
Perhaps because of Brazil’s relatively low prevalence
of paediatric HIV/AIDS, the literature on both the
prevalence and welfare related to AIDS orphans in
Brazil is sparse. We nevertheless discuss the available
information and its implications for assessing the
Brazilian policy response to addressing the welfare
needs of children affected by AIDS.
It is not known precisely how many AIDS orphans
live in Brazil today (Doring et al. 2005). Using
mathematical models, in 2000 Szwarcwald and
co-workers estimated that 30,000 children were
orphaned in Brazil due to maternal AIDS during
1987–99 (Szwarcwald et al. 2000). Other studies
reviewed by França Junior et al. (2006) used
alternative methods to estimate the number of AIDS
orphans in Brazil, but the accuracy of the estimates
have been somewhat compromised by data
limitations.
In perhaps the best formal study carried out to date on
AIDS orphans in Brazil, a 2005 article estimates the
number of orphans in Rio Grande do Sul, a well-
developed state in southern Brazil. The authors found
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that 1,131 orphans (defined as the loss of either one or
both of their parents) aged 0–14 were living in the
capital, Porto Alegre, in the period 1998–2001. The
city’s AIDS prevalence ranks third highest in the
country, after São Paulo and Rio de Janeiro (Doring et
al. 2005). While this study may not represent broader
Brazilian trends, it does provide some insight into the
public policy response to the welfare needs of children
affected and infected with HIV in a Brazilian state with
relatively high HIV/AIDS prevalence.
The study, based on household surveys of AIDS
orphans, finds that informal networks of relatives
and friends have been equally important in
addressing orphans’ social needs. Of the orphans
interviewed for the study, approximately 95 per cent
were not living in orphanages or public institutions at
the time of the survey. Half the orphans were living
with their extended families; one-quarter lived with
their other parent, and another quarter lived with
relatives, friends and neighbours in informal
arrangements. Nearly 75 per cent of the orphans
reported receiving counselling and testing for HIV,
and HIV prevalence was 9 per cent among all
orphans who had been tested (Doring et al. 2005).
This first study suggests that informal networks of
relatives and friends who received minimal or no
financial or social support from the state have been a
fundamental component of support systems for
orphans. Although UNAIDS recommends avoiding
institutionalisation of AIDS orphans when stable
networks of families and friends are available
(UNAIDS 2006b), the only study on the welfare of
AIDS orphans in Brazil suggests that improving public
infrastructure to address orphans’ social needs might
bolster existing efforts, particularly since the study
reports that orphans face significant problems with
social marginalisation and stigma (Doring et al. 2005).
Using Bolsa Família, Brazil’s direct cash transfer
programme for families living in abject poverty, might
be an important outlet for initial outreach efforts.
To date, no research has examined non-orphan
children affected by HIV/AIDS in Brazil. Further
research is needed to examine the social and welfare
needs of AIDS orphans in Brazil outside of Rio
Grande do Sul, as well as non-orphaned children
made vulnerable by HIV/AIDS in greater Brazil.
Because most orphans are from low socioeconomic
strata, these studies should be situated in the context
of poverty and social exclusion.
6 Conclusions
We conclude that the impact of AIDS on Brazilian
children has been largely mitigated by the timely
implementation of measures to prevent vertical HIV
transmission. To date, little is known about the health
and social welfare of children affected and infected by
HIV/AIDS; the small number of paediatric AIDS cases
in Brazil have resulted in relatively little scientific
research related to the welfare of children affected
and infected by HIV/AIDS in Brazil. However, the
Brazilian government has committed to providing free
and universal access to AIDS treatment for all
children living with HIV, has implemented health
infrastructure towards that end, and currently treats
over 7,000 children living with HIV/AIDS.
By using World Bank loans to subsidise AIDS
programmes and health infrastructure development
while locally financing the drugs necessary for treating
AIDS and the prevention of vertical HIV transmission,
Brazil has successfully mitigated the impact of the
HIV/AIDS epidemic on children. Although no studies
have explicitly examined the macroeconomic impacts
of World Bank loans for HIV/AIDS in Brazil, with an
economy of over US$1 trillion and annual public health
spending of approximately US$20 billion, foreign aid
related to HIV/AIDS in Brazil seems not to have
distorted Brazil’s economic development or national
health programmes. Brazil, with relatively well-
developed health infrastructure, low HIV prevalence,
progressive public policy responses to the AIDS
epidemic, early receipt of foreign aid for HIV/AIDS, a
large economy, and a large health portfolio
undistorted by foreign aid, is an exceptional case of a
developing country response to HIV/AIDS. We
nevertheless conclude that by largely preventing
vertical transmission of HIV/AIDS, and disregarding
donor advice about prioritising prevention over AIDS
treatment, Brazil has successfully avoided what could
have been a major public health crisis related to
paediatric HIV/AIDS.
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Notes
1 Peripartum refers to the time before, during or
just after delivery.
2 We do not explore the clinical guidelines in detail
in this article. However, these newly updated
guidelines are available in a report published by
the National STD and AIDS Program of Brazil
(Programa Nacional de DST e Aids 2007).
3 Brazil defines children as those aged 1–12 and
adolescents as those aged 13–19. In this article,
we differentiate our analyses in this way.
4 Epidemiologists debate why paediatric AIDS cases
increased slightly after 2003. The slight increase
may either reflect a true increase in paediatric
AIDS due to increased incidence in select
geographic regions, or may be a consequence of
improved surveillance and case reporting. These
estimates are currently under study by the
National STD and AIDS Program of Brazil.
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